Biotechnology

3000+ Companies
More info
Parent markets
Sibling markets
Related markets
3000+ companies in Biotechnology
Show all
Pfizer Belgium

Pfizer Belgium

Medical +2
23andMe

23andMe

Biotechnology +3
Celgene Corporation

Celgene Corporation

Medical +1
Gilead Sciences

Gilead Sciences

Biotechnology
Merck

Merck

Health Care +2
AbbVie

AbbVie

Biotechnology +1
Amgen Inc.

Amgen Inc.

Manufacturing +2
Biogen

Biogen

Biotechnology
GlaxoSmithKline

GlaxoSmithKline

Health and Wellness +2
BiotechZone

BiotechZone

E-Commerce +3
Roche

Roche

Biotechnology +3
Regeneron

Regeneron

Biotechnology
Allergan plc

Allergan plc

Biotechnology +1
Exact Sciences

Exact Sciences

Biotechnology +1
Jane

Jane

Medical +3
All companies in Biotechnology
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Companies
3,161
Booming
Add companies
Deals 2019 Q1
77 investments
1 acquisition
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Upgrade account
MedCity News

NeuroSigma wins FDA nod for first non-drug ADHD treatment

NeuroSigma
NeuroSigma
PE Hub

Sofinnova hires Maha Katabi as partner, will open Montréal office

FinSMEs

Lilly and Avidity Biosciences Sign Licensing and Research Collaboration Deal

Avidity Biosciences
Avidity Biosciences
FinSMEs

Imbed Biosciences Closes $2M Series A Financing

Imbed Biosciences
Imbed Biosciences
PE Hub

Hookipa Pharma debuts IPO

Hookipa Pharma
Hookipa Pharma
$6,200,000 Venture capital (Series A)
FinSMEs

SilkTech Biopharmaceuticals Raises $6.2M in Additional Funding

Silk Technologies
Silk Technologies
PE Hub

VC-backed EarlySense taps Johnson as CEO

FinSMEs

Checkerspot Closes $13M Series A Funding Round

Checkerspot
Checkerspot
New York Times Bits

Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns

23andMe
23andMe
GeekWire

Inside Arzeda’s synthetic biology lab, where industrial ingredients are brewed like beer

Robotics
Arzeda
Arzeda
Xconomy

Xconomy: Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval

Xconomy
Xconomy
Achaogen
Achaogen
Xconomy

Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout

Celgene Corporation
Celgene Corporation
Xconomy

San Diego Life Sciences Roundup: Evofem, Cullgen, BrainLeap & More

Cullgen
Cullgen
FinSMEs

Embark Veterinary Raises $10M in Series A Funding

Embark Veterinary
Embark Veterinary
$10,000,000 Venture capital (Series A)
PE Hub

Embark Veterinary fetches $10 mln Series A

Embark Veterinary
Embark Veterinary
$4,100,000 Seed fund
FinSMEs

Fauna Bio Raises 4.1M in Seed Funding

faunabio
faunabio
$16,000,000 Venture capital (Series A)
FinSMEs , PE Hub

Cullgen Receives $16M in Series A Funding

Cullgen
Cullgen
$15,000,000 Venture capital (Series B)
FinSMEs , PE Hub

EdiGENE Raises $15M in Series B Funding

EdiGENE
EdiGENE
FinSMEs

Noveome Biotherapeutics Completes $15M Series D Financing

Biotherapeutics
Biotherapeutics
Noveome
Noveome
Xconomy

FDA Refuses to Review Zogenix Seizure Drug, Says File Not Complete

Zogenix
Zogenix